Viewing Study NCT07266766


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-25 @ 2:26 PM
Study NCT ID: NCT07266766
Status: COMPLETED
Last Update Posted: 2025-12-05
First Post: 2025-11-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg
Sponsor: Humanis Saglık Anonim Sirketi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module